Literature DB >> 25995261

A Novel Leu92 Mutant of HIV-1 Reverse Transcriptase with a Selective Deficiency in Strand Transfer Causes a Loss of Viral Replication.

Eytan Herzig1, Nickolay Voronin1, Nataly Kucherenko2, Amnon Hizi3.   

Abstract

UNLABELLED: The process of reverse transcription (RTN) in retroviruses is essential to the viral life cycle. This key process is catalyzed exclusively by the viral reverse transcriptase (RT) that copies the viral RNA into DNA by its DNA polymerase activity, while concomitantly removing the original RNA template by its RNase H activity. During RTN, the combination between DNA synthesis and RNA hydrolysis leads to strand transfers (or template switches) that are critical for the completion of RTN. The balance between these RT-driven activities was considered to be the sole reason for strand transfers. Nevertheless, we show here that a specific mutation in HIV-1 RT (L92P) that does not affect the DNA polymerase and RNase H activities abolishes strand transfer. There is also a good correlation between this complete loss of the RT's strand transfer to the loss of the DNA clamp activity of the RT, discovered recently by us. This finding indicates a mechanistic linkage between these two functions and that they are both direct and unique functions of the RT (apart from DNA synthesis and RNA degradation). Furthermore, when the RT's L92P mutant was introduced into an infectious HIV-1 clone, it lost viral replication, due to inefficient intracellular strand transfers during RTN, thus supporting the in vitro data. As far as we know, this is the first report on RT mutants that specifically and directly impair RT-associated strand transfers. Therefore, targeting residue Leu92 may be helpful in selectively blocking this RT activity and consequently HIV-1 infectivity and pathogenesis. IMPORTANCE: Reverse transcription in retroviruses is essential for the viral life cycle. This multistep process is catalyzed by viral reverse transcriptase, which copies the viral RNA into DNA by its DNA polymerase activity (while concomitantly removing the RNA template by its RNase H activity). The combination and balance between synthesis and hydrolysis lead to strand transfers that are critical for reverse transcription completion. We show here for the first time that a single mutation in HIV-1 reverse transcriptase (L92P) selectively abolishes strand transfers without affecting the enzyme's DNA polymerase and RNase H functions. When this mutation was introduced into an infectious HIV-1 clone, viral replication was lost due to an impaired intracellular strand transfer, thus supporting the in vitro data. Therefore, finding novel drugs that target HIV-1 reverse transcriptase Leu92 may be beneficial for developing new potent and selective inhibitors of retroviral reverse transcription that will obstruct HIV-1 infectivity.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25995261      PMCID: PMC4524244          DOI: 10.1128/JVI.00809-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.

Authors:  Z Sevilya; S Loya; N Adir; A Hizi
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

2.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.

Authors:  J Kimpton; M Emerman
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 3.  Strand transfer events during HIV-1 reverse transcription.

Authors:  Vandana Purohit Basu; Min Song; Lu Gao; Sean T Rigby; Mark Nils Hanson; Robert A Bambara
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

4.  Identification of a major co-receptor for primary isolates of HIV-1.

Authors:  H Deng; R Liu; W Ellmeier; S Choe; D Unutmaz; M Burkhart; P Di Marzio; S Marmon; R E Sutton; C M Hill; C B Davis; S C Peiper; T J Schall; D R Littman; N R Landau
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

5.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

6.  Nontemplated nucleotide addition by HIV-1 reverse transcriptase.

Authors:  Marie-Pierre Golinelli; Stephen H Hughes
Journal:  Biochemistry       Date:  2002-05-07       Impact factor: 3.162

7.  Increased polymerase fidelity of E89G, a nucleoside analog-resistant variant of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  W C Drosopoulos; V R Prasad
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Expression and characterization of a recombinant novel reverse transcriptase of a porcine endogenous retrovirus.

Authors:  Orna Avidan; Shoshana Loya; Ralf R Tönjes; Ziv Sevilya; Amnon Hizi
Journal:  Virology       Date:  2003-03-15       Impact factor: 3.616

9.  Mutagenesis of cysteine 280 of the reverse transcriptase of human immunodeficiency virus type-1: the effects on the ribonuclease H activity.

Authors:  Ziv Sevilya; Shoshana Loya; Amit Duvshani; Noam Adir; Amnon Hizi
Journal:  J Mol Biol       Date:  2003-03-14       Impact factor: 5.469

10.  Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.

Authors:  Elena N Peletskaya; Alex A Kogon; Steven Tuske; Edward Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more
  3 in total

1.  Template-primer binding affinity and RNase H cleavage specificity contribute to the strand transfer efficiency of HIV-1 reverse transcriptase.

Authors:  Joanna Luczkowiak; Tania Matamoros; Luis Menéndez-Arias
Journal:  J Biol Chem       Date:  2018-07-10       Impact factor: 5.157

2.  Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.

Authors:  Doty B A Ojwach; Paradise Madlala; Michelle Gordon; Thumbi Ndung'u; Jaclyn K Mann
Journal:  Virology       Date:  2020-12-10       Impact factor: 3.616

3.  HIV-1 infection increases microRNAs that inhibit Dicer1, HRB and HIV-EP2, thereby reducing viral replication.

Authors:  Shira Modai; Luba Farberov; Eytan Herzig; Ofer Isakov; Amnon Hizi; Noam Shomron
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.